rfhg_152860.1

Basic information about the TSS

---

TSS ID: rfhg_152860.1 TSS ID(Version3): hg_126456.1 hg_126455.1 Species: human Chr: chr12		Start: 64610415 End: 64610504 Strand: +
Source datasets	FANTOM5|EPD|DRA013844|PRJNA4843412|PRJNA615891|PRJNA401781 |PRJNA548673
Protocol	CAGE|TSS_database|NETCAGE|SLIC_CAGE|ReCappable-seq
TSS cluster detected*	8

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2569852,EH38E1619714)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000542104.6:0 GeneID: 283349 HGNC/MGI_ID: HGNC:14271 UniProt_ID: Q86WH2 Nearer transcript ids and distances: ENST00000336061.2:9 ENST00000283172.8:9 BC100949:9 BC100950:9 BC100951:9 BC100952:9 AY217662:9 AY217663:9 ENST00000540088.1:18 KJ900547:123 view more...

Gene_name: Ras association domain family member 3 Gene_symbol: RASSF3 Gene_synonyms: Gene_source: HGNC:14271

TATA-Box annotation

---

Distance to TSS:	-36
Nearest PromoterID:	NR_040718
Entrez ID:	283349
Nearest Unigene:	Hs.643605
Nearest Refseq:	NM_178169
Nearest Ensembl:	ENSG00000153179
Gene Name:	Ras association domain family member 3
Gene Alias:	RASSF5
Gene Type:	protein-coding
CpG%:	0.134831
GC%:	0.811111
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RASSF3 p2@RASSF3 p3@RASSF3 p4@RASSF3 p5@RASSF3 p6@RASSF3
Sample		p1@RASSF3	p2@RASSF3	p3@RASSF3	p4@RASSF3	p5@RASSF3	p6@RASSF3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	8.38	2.14	2.53	0.97	0.19	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.09	3.03	4.65	0.40	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.33	1.93	4.82	0.77	0.00	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.24	2.08	5.41	1.04	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	9.00	1.35	4.05	0.00	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7.17	2.13	6.40	0.19	0.19	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	7.41	3.70	4.14	0.22	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6.30	1.70	5.57	0.00	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	7.27	3.63	3.85	0.21	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	11.59	2.32	6.38	1.16	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	14.15	1.62	2.83	0.81	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	13.82	1.22	6.91	1.22	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.41	4.84	2.58	2.58	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.53	4.21	2.26	2.10	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	15.59	4.83	2.85	3.73	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.58	4.02	2.26	1.26	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.05	2.40	1.31	2.18	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.81	2.11	1.69	2.11	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.73	3.20	1.07	1.60	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.19	5.87	2.11	2.26	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	16.71	3.34	2.00	1.74	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	14.67	4.66	1.38	2.24	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	12.54	3.36	1.29	2.07	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.02	3.15	1.46	3.64	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	15.48	3.87	2.32	2.58	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	14.88	1.58	1.27	2.22	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.64	1.65	1.65	1.65	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	14.85	4.95	1.65	1.89	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.28	3.55	3.07	2.26	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.30	5.07	1.81	2.17	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	13.19	3.35	1.47	1.67	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	16.41	3.91	2.34	2.74	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	15.19	2.53	2.11	1.69	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	10.23	1.98	1.81	1.32	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	12.72	3.18	3.55	1.87	0.93	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	15.90	4.60	1.72	1.92	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.24	2.04	1.02	1.64	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.29	1.81	1.61	1.81	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	14.32	4.32	1.35	1.35	1.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	12.48	2.64	3.36	1.20	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	10.35	2.12	2.12	1.18	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.86	1.32	2.05	1.02	0.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.33	2.95	1.90	2.53	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	14.69	4.02	1.92	2.45	0.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.85	2.61	2.01	2.81	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.70	4.19	1.16	2.33	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	12.72	2.88	2.88	1.92	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.80	3.87	4.47	0.60	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.05	5.51	2.63	1.68	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	13.55	4.04	1.21	1.42	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.02	3.89	2.25	1.84	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	13.12	1.56	1.56	1.11	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	13.99	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.58	4.97	2.48	2.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.95	3.31	1.33	1.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	0.00	1.68	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	6.89	1.84	1.38	0.92	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.10	6.81	1.62	1.62	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.88	5.78	2.25	1.61	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.97	2.20	2.20	1.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	2.82	2.82	1.41	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.02	2.24	2.24	1.12	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	13.53	3.18	2.39	3.18	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	13.93	3.06	2.72	3.40	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.92	5.85	1.30	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.13	4.97	3.19	2.48	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	7.90	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.48	4.88	2.44	2.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	18.84	8.93	2.48	1.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	18.76	7.97	4.22	1.88	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.88	4.31	1.66	3.97	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	18.87	6.81	1.86	2.47	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	16.82	6.11	1.53	3.06	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	9.66	2.69	8.55	1.27	0.16	0.63
Adipocyte - breast, donor2	11327-117E4	6.58	2.73	3.85	1.60	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	9.29	2.29	8.52	1.02	0.38	0.25
Adipocyte - omental, donor2	11474-119C7	15.70	2.24	8.22	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	10.38	3.01	5.02	1.34	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	2.55	2.55	7.66	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	2.20	1.10	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	1.81	0.90	1.81	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	1.56	1.04	1.04	0.70	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	8.80	5.48	2.54	1.37	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	6.43	4.38	2.57	1.03	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	6.13	2.79	1.67	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	7.05	3.53	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	13.51	3.14	3.86	1.69	0.24	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	16.14	4.20	1.94	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	1.07	1.07	1.60	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.02	0.56	3.34	1.11	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	7.90	1.25	1.66	1.25	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.32	2.26	2.26	1.26	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.80	1.31	2.95	0.65	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	8.83	4.57	1.22	1.22	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	35.58	7.51	4.20	3.31	0.66	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	12.55	2.87	1.08	2.15	0.36	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	1.20	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	8.46	4.86	1.98	0.00	0.18	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.96	2.47	1.44	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	1.26	0.57	0.69	0.00	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	0.98	0.73	0.49	0.24	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.23	2.25	1.80	0.90	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.29	1.74	3.47	2.60	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	2.14	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.57	2.99	3.29	1.20	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	2.53	6.32	1.26	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	2.64	1.98	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.40	3.90	3.90	1.62	0.97	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	8.74	2.43	4.85	0.97	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.28	2.97	3.56	1.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.42	1.13	4.52	0.75	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	12.34	6.53	5.81	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	5.02	7.52	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.70	2.47	4.45	1.48	0.49	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	4.09	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.68	4.37	5.43	1.81	0.60	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.04	2.68	3.21	1.07	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	11.34	2.65	2.83	1.32	0.57	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.62	1.60	4.28	1.34	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	4.88	2.93	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.45	3.15	4.64	1.33	0.50	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	1.20	8.41	3.60	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	7.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.09	4.46	4.12	1.20	0.51	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	11.16	2.43	6.31	1.46	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.97	6.07	7.97	1.14	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	1.21	2.42	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.70	1.71	4.56	1.71	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.90	2.78	4.70	2.57	0.64	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.78	1.55	4.13	2.06	1.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.04	1.88	3.75	0.00	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.25	3.54	2.89	1.29	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	2.85	2.85	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.36	2.34	5.85	1.75	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.63	2.71	4.52	1.20	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	2.38	1.19	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.65	3.56	3.56	1.53	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.13	3.82	3.31	2.04	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	3.18	5.72	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.65	3.45	4.32	1.29	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.43	4.02	3.81	1.27	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.28	1.16	2.90	1.16	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	0.94	7.56	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	10.51	4.75	2.20	1.19	1.36	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	4.63	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	2.11	4.23	2.11	2.11	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.01	2.57	4.07	2.57	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.23	0.60	2.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.75	2.19	3.64	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	11.72	3.45	2.53	1.84	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	5.10	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	21.61	3.81	6.36	1.53	0.51	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	14.04	3.92	6.19	1.24	0.83	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.02	1.84	3.06	3.98	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.60	3.82	7.17	2.39	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	15.52	2.00	5.32	1.11	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	1.53	4.58	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.65	2.77	4.98	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.86	4.24	5.56	2.65	1.32	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.72	1.09	5.45	1.45	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	5.28	3.93	4.05	0.86	0.00	0.25
Astrocyte - cerebellum, donor2	11580-120F5	8.04	4.96	2.91	2.05	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	9.65	2.73	1.68	1.47	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	3.49	1.74	2.79	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	6.96	3.24	1.46	0.81	0.32	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	10.44	4.77	3.13	1.19	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	19.15	16.40	8.72	2.29	0.23	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	16.29	11.78	8.77	1.75	0.38	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	17.30	13.43	7.28	0.80	0.34	0.91
Basophils, donor1	12241-129G9	49.17	8.37	14.65	3.40	0.26	2.09
Basophils, donor2	12242-129H1	73.96	11.55	18.04	2.16	0.36	3.25
Basophils, donor3	12243-129H2	37.04	11.47	10.58	3.09	0.73	1.47
Bronchial Epithelial Cell, donor1	11511-119G8	2.59	1.51	0.43	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.37	2.29	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.77	3.77	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	2.91	3.74	1.87	0.62	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	3.22	1.84	1.15	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	2.88	2.16	0.72	0.54	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	24.84	9.58	3.40	1.96	0.72	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	34.24	15.84	3.96	3.26	0.93	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	10.55	7.67	7.35	0.96	0.32	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	59.17	15.22	27.05	6.76	1.69	2.25
CD14+ Monocytes, donor2	11305-117B9	72.94	9.09	26.54	7.42	1.86	2.78
CD14+ Monocytes, donor3	11381-118B4	65.20	14.05	21.08	4.39	2.63	2.20
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	77.84	18.11	18.96	5.38	0.85	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	128.13	22.37	14.78	10.99	3.03	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	113.09	27.29	19.72	8.55	2.63	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	104.36	18.21	29.20	7.08	2.02	4.19
CD14+ monocytes - mock treated, donor2	11873-125C1	86.30	14.48	24.74	5.43	1.81	2.11
CD14+ monocytes - mock treated, donor3	11883-125D2	106.13	20.14	48.56	5.69	2.13	3.32
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	54.40	8.54	26.62	3.85	1.00	2.85
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	55.75	7.73	24.29	4.14	1.66	4.14
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	34.96	9.17	33.72	2.48	0.50	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	77.54	8.81	31.72	3.13	4.31	2.15
CD14+ monocytes - treated with BCG, donor2	11870-125B7	99.53	14.96	29.20	5.52	2.85	3.74
CD14+ monocytes - treated with BCG, donor3	11880-125C8	106.86	10.01	49.40	4.13	2.83	4.57
CD14+ monocytes - treated with Candida, donor1	11868-125B5	100.44	15.69	45.42	9.37	11.00	2.81
CD14+ monocytes - treated with Candida, donor2	11878-125C6	103.49	20.59	36.43	8.45	10.56	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	53.25	7.77	45.48	4.44	7.77	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	55.48	10.26	25.44	3.57	1.04	1.93
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	42.30	10.38	21.75	4.39	1.20	2.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	55.17	7.29	26.65	3.96	0.83	3.12
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	89.91	14.87	41.41	7.55	13.27	3.66
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	109.94	13.80	44.34	5.43	7.69	2.49
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	86.42	12.22	49.32	4.36	13.53	4.80
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	112.98	19.10	37.12	10.22	1.61	4.03
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	132.24	19.37	35.42	11.51	4.54	2.97
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	153.60	21.88	58.91	7.15	5.89	3.79
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	43.36	6.61	31.23	2.02	1.47	4.41
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	66.23	14.09	45.09	5.64	1.76	3.52
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	50.01	6.58	47.82	0.88	0.88	3.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	60.51	9.07	27.73	3.84	4.53	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	72.48	14.87	36.42	3.72	2.60	2.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	82.56	9.48	50.44	4.31	3.45	2.16
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	36.44	8.19	25.39	1.64	0.82	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	54.24	7.88	32.22	3.01	1.16	2.55
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	45.01	9.28	34.57	1.16	0.93	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	44.25	8.72	25.94	3.71	0.44	2.18
CD14+CD16+ Monocytes, donor2	11801-124D1	46.43	8.55	23.10	2.77	0.23	2.77
CD14+CD16+ Monocytes, donor3	11912-125G4	48.96	9.53	25.99	4.33	0.00	2.82
CD14+CD16- Monocytes, donor1	11788-124B6	114.46	15.11	23.83	8.72	0.62	2.80
CD14+CD16- Monocytes, donor2	11799-124C8	105.31	18.34	20.26	8.38	0.70	3.67
CD14+CD16- Monocytes, donor3	11910-125G2	160.98	23.86	33.89	9.81	1.34	3.79
CD14-CD16+ Monocytes, donor1	11790-124B8	47.72	5.87	25.77	2.81	0.26	2.81
CD14-CD16+ Monocytes, donor2	11800-124C9	38.64	8.34	21.96	3.51	0.88	3.73
CD14-CD16+ Monocytes, donor3	11911-125G3	48.00	9.69	26.53	3.16	0.42	3.37
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	14.23	12.19	0.00	2.03	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	67.12	40.68	16.27	2.03	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	37.28	27.96	20.71	1.04	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	61.83	23.99	19.19	0.00	1.07	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	62.18	27.34	13.94	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	44.22	26.67	19.65	1.40	0.00	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	56.47	18.04	10.20	2.35	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	64.60	29.00	17.14	1.32	0.00	2.64
CD19+ B Cells, donor1	11544-120B5	38.63	18.90	13.97	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	37.72	10.16	13.78	0.73	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	46.44	17.16	15.14	0.50	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.40	0.40	0.81	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.40	0.80	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	6.02	3.01	2.01	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	25.84	5.06	12.92	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	15.78	9.39	3.76	0.75	1.13	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	13.08	8.57	5.64	1.58	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	122.47	34.28	31.78	4.28	1.43	3.57
CD4+ T Cells, donor2	11306-117C1	116.35	28.17	32.46	5.51	1.84	1.84
CD4+ T Cells, donor3	11382-118B5	142.43	27.14	26.84	8.54	1.83	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	130.43	19.91	15.06	6.64	1.28	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	125.77	21.56	15.27	7.19	1.57	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	147.47	25.87	23.00	4.89	0.86	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	148.86	41.25	53.57	6.64	0.47	5.69
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	149.59	37.22	42.14	6.32	1.40	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	135.15	29.67	39.55	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	71.39	16.19	7.23	4.05	0.43	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	80.83	17.12	9.66	4.74	0.85	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	67.71	15.31	6.93	3.71	0.81	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	143.90	29.59	27.79	9.86	0.90	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	138.71	32.49	28.30	6.99	1.40	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	166.75	23.76	31.24	4.40	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	88.12	12.65	9.28	3.79	0.42	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	49.86	11.84	7.90	2.91	0.42	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	44.10	8.69	5.35	2.34	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	158.27	31.82	30.73	6.53	0.27	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	195.62	46.63	35.37	5.90	2.68	3.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	139.87	25.11	32.28	8.97	3.59	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	128.69	20.95	7.60	6.68	1.85	1.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	97.26	16.68	8.66	6.50	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	114.11	21.86	10.30	4.20	2.52	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	133.48	24.27	22.25	8.09	2.53	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	120.88	27.73	25.56	5.63	3.03	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	156.02	24.41	21.79	3.92	1.31	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	151.43	36.13	25.24	10.89	1.48	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	101.55	37.85	29.54	2.77	2.77	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	93.52	22.33	26.52	0.00	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	104.68	37.94	23.82	4.43	1.38	3.05
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	125.89	39.02	28.47	7.36	1.96	2.94
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	155.54	26.18	30.80	13.86	3.08	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	136.80	40.11	27.58	6.45	0.72	3.22
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	145.42	23.54	24.93	8.31	1.38	4.15
CD8+ T Cells, donor1	11226-116C2	83.81	18.01	19.64	2.62	0.00	2.95
CD8+ T Cells, donor2	11307-117C2	57.82	10.14	18.77	1.88	0.75	2.25
CD8+ T Cells, donor3	11383-118B6	81.30	26.26	21.71	2.27	1.77	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	9.63	7.11	5.05	0.92	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.95	4.79	4.55	1.20	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	12.04	4.10	5.47	1.64	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.60	3.60	6.30	2.40	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.44	7.20	9.36	0.72	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	7.73	5.68	7.05	1.59	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.34	5.87	5.87	1.52	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.58	6.58	6.58	1.32	0.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.24	6.80	7.97	1.64	0.23	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	12.98	7.55	6.94	0.91	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.04	4.65	3.49	0.87	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	15.45	6.39	5.60	0.53	0.80	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	31.08	7.88	9.19	5.25	3.94	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	29.60	13.21	3.64	4.10	6.38	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	35.80	6.71	5.22	6.71	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.80	9.00	7.20	1.80	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.65	9.21	12.95	1.44	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	11.55	7.54	9.66	1.18	0.24	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	13.31	3.80	7.92	1.90	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.69	9.53	5.23	2.77	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	11.54	8.34	8.34	2.56	0.00	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	13.39	7.27	6.88	3.06	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	10.64	7.88	4.34	0.39	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	8.32	3.78	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	27.30	5.62	8.03	1.61	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	28.68	7.69	3.50	2.10	3.50	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	27.05	10.02	10.02	1.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	5.48	0.00	9.14	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	6.92	0.49	2.96	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	7.05	4.00	2.42	0.74	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	5.20	2.77	1.73	0.00	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	6.04	0.71	3.20	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	1.71	1.02	1.48	0.11	0.11	0.00
Chondrocyte - re diff, donor2	11339-117F7	2.69	1.79	3.58	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	0.81	2.02	2.02	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	16.53	5.05	8.38	2.07	0.23	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	15.82	5.13	6.41	2.35	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	19.82	6.02	5.66	4.07	1.06	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	26.87	9.72	12.56	2.11	0.83	1.01
Corneal Epithelial Cells, donor1	11526-119I5	1.54	1.54	1.54	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	1.14	2.28	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	1.28	2.81	1.02	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	36.65	14.69	19.15	2.15	0.66	2.15
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	37.22	17.03	19.56	1.58	0.00	2.52
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	0.00	3.45	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.44	10.91	9.72	1.40	0.65	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	14.35	8.20	5.12	0.34	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	15.02	7.18	3.26	1.96	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	15.97	12.10	3.39	1.45	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	35.86	7.17	2.84	4.67	0.83	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	25.23	4.69	2.35	3.52	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	39.03	10.18	5.09	4.81	0.28	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	37.75	4.72	3.54	4.72	0.79	0.39
Endothelial Cells - Artery, donor1	11264-116G4	31.41	6.40	2.33	1.75	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	33.88	9.41	3.53	3.06	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	29.28	6.84	3.86	3.16	0.88	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	30.37	7.54	5.10	3.99	1.33	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	49.60	10.65	3.04	5.78	1.83	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	33.26	6.48	5.64	3.38	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	13.97	5.65	4.46	1.49	0.00	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	28.64	8.85	5.21	3.12	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	12.05	3.69	1.84	1.13	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	33.61	13.60	7.60	2.80	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	19.39	6.29	5.24	2.62	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	27.71	10.19	4.22	2.73	1.37	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.76	7.17	3.69	4.35	1.09	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	28.33	14.04	3.91	3.54	0.98	0.49
Endothelial Cells - Vein, donor1	11267-116G7	25.03	9.10	1.14	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	38.42	11.87	4.19	4.19	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	35.64	10.52	3.93	5.02	0.94	0.31
Eosinophils, donor1	12244-129H3	182.96	45.74	45.74	15.25	0.00	15.25
Eosinophils, donor2	12245-129H4	529.73	113.87	262.39	14.85	8.25	13.20
Eosinophils, donor3	12246-129H5	438.72	57.07	156.94	10.70	3.57	32.10
Esophageal Epithelial Cells, donor1	11507-119G4	3.42	2.69	0.49	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	6.98	0.41	0.41	0.41	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.04	1.64	1.75	0.33	0.33	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	3.58	1.52	2.28	1.63	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	13.34	3.40	4.12	0.97	0.36	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	8.73	4.09	4.78	0.27	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.91	3.06	4.01	1.16	0.53	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	5.53	3.43	0.53	1.05	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.62	4.65	1.99	1.66	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	12.70	3.63	2.72	4.54	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	2.27	3.79	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	9.94	3.63	4.10	1.73	0.32	0.16
Fibroblast - Cardiac, donor4	11452-119A3	13.03	4.85	5.15	2.42	0.00	0.91
Fibroblast - Cardiac, donor5	11456-119A7	13.83	3.05	3.43	2.28	0.76	0.76
Fibroblast - Cardiac, donor6	11460-119B2	13.95	5.31	3.94	2.27	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	7.77	3.22	5.90	1.34	0.00	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	7.77	2.16	4.31	0.86	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	5.86	8.79	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	15.68	5.30	2.77	1.61	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	11.02	2.37	5.09	1.53	0.17	0.51
Fibroblast - Dermal, donor1	11269-116G9	4.23	3.05	1.88	0.70	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	11.79	3.77	3.30	1.89	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	2.90	3.26	2.18	0.00	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	4.18	4.52	1.81	0.57	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	4.71	5.41	1.40	0.70	0.00	0.52
Fibroblast - Dermal, donor6	11458-119A9	7.47	5.68	1.62	1.30	0.49	0.16
Fibroblast - Gingival, donor1	11237-116D4	7.29	3.75	1.67	0.21	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	18.86	6.81	5.76	4.72	0.52	1.31
Fibroblast - Gingival, donor2	11318-117D4	7.51	3.82	1.58	0.53	0.53	0.40
Fibroblast - Gingival, donor3	11394-118C8	7.44	3.38	2.61	1.16	0.10	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	25.97	4.16	6.23	2.08	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	26.96	6.17	6.52	6.17	0.53	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	9.67	5.30	3.27	2.18	0.94	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	7.17	3.38	1.76	1.62	0.41	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	12.70	3.53	7.76	3.53	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	11.99	4.09	5.41	2.19	0.00	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	10.23	3.14	3.27	1.77	0.41	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	12.07	6.25	4.50	2.63	0.33	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.79	2.49	6.02	2.93	0.00	0.44
Fibroblast - Lung, donor1	11270-116H1	17.67	0.00	2.72	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	19.40	4.48	8.95	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	8.02	5.49	2.95	0.42	0.42	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	10.00	6.66	6.66	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	2.80	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.88	1.12	2.80	0.56	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	9.74	6.09	6.50	2.03	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	11.91	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	4.46	5.63	1.75	0.19	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.22	5.01	2.43	1.06	0.00	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	15.91	10.40	4.90	0.31	0.61	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.90	8.40	5.34	2.67	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.23	2.16	4.59	1.62	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	20.53	5.80	8.12	5.22	0.81	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	10.72	4.75	4.09	1.11	0.22	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	25.60	7.31	5.89	2.24	1.22	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.68	2.67	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	3.95	4.35	1.98	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	3.37	1.79	2.18	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	5.68	3.55	3.73	0.71	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	8.28	3.35	3.55	0.00	0.00	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1.81	1.50	1.20	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	4.10	3.24	3.24	0.65	0.22	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	2.78	0.76	1.27	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	6.40	2.79	3.12	0.16	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	4.21	1.40	2.01	0.00	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	5.32	4.62	3.52	0.90	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	2.12	2.42	1.51	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	8.28	3.65	4.97	0.99	0.17	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	5.30	3.59	2.56	0.85	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1.97	1.64	1.31	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	8.42	4.15	4.15	1.17	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	6.24	3.20	4.72	0.51	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	4.39	0.16	1.25	0.31	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	4.36	2.61	3.49	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	6.07	1.91	2.08	0.52	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	6.51	4.42	0.26	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	4.60	5.37	0.51	1.02	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	12.25	6.12	10.72	0.77	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.23	8.29	8.29	1.28	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	22.25	8.56	13.41	2.57	0.29	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	10.75	7.17	6.89	1.10	0.00	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	10.96	5.02	5.25	1.14	0.23	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	17.04	9.91	14.07	1.98	0.20	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	10.84	4.49	7.14	0.53	0.26	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	14.02	3.26	5.22	0.98	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	18.57	9.29	16.36	2.21	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	16.68	7.49	9.61	1.41	0.42	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	13.18	6.90	7.14	1.60	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	11.55	7.79	5.37	1.07	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	13.26	5.33	7.68	0.12	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	16.89	9.27	10.38	2.08	0.69	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.86	6.10	6.51	1.02	0.41	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.38	3.65	5.70	1.14	0.23	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.05	7.10	4.61	2.37	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	23.61	11.80	7.43	3.93	0.87	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.59	4.14	5.61	1.48	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	13.83	6.04	5.88	1.27	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	15.42	6.48	6.26	2.23	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	20.57	6.25	5.65	1.41	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.76	5.60	6.28	1.70	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	21.81	6.92	8.60	1.77	0.89	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.52	9.78	7.91	3.64	0.52	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.28	7.00	10.93	3.24	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	22.79	6.97	6.97	3.43	1.00	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.88	6.16	8.24	1.91	0.25	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	26.75	7.76	8.58	3.06	0.20	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	14.85	3.30	5.16	1.65	0.21	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	21.79	7.61	8.99	2.54	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	25.35	4.67	7.17	2.50	0.67	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.89	4.85	3.97	2.42	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	27.92	8.49	9.10	1.97	0.61	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	18.32	7.13	4.05	3.40	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	21.17	4.17	5.13	0.64	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	24.83	7.77	7.01	2.27	1.04	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.79	9.33	7.75	3.64	0.95	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	25.54	6.99	6.69	2.13	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	27.08	6.79	7.63	3.14	0.52	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	25.91	6.15	6.37	1.32	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.92	5.89	5.05	2.24	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	28.98	8.33	7.13	3.33	0.56	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	32.89	5.62	8.29	3.48	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	36.72	5.97	5.05	4.90	0.92	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	30.18	8.68	6.22	3.89	0.91	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	30.36	5.96	6.23	4.07	2.17	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.02	5.53	7.56	2.03	0.74	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	17.55	3.73	5.92	2.19	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	30.74	8.93	5.95	3.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	14.51	4.09	7.65	1.06	0.92	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.52	3.03	5.04	2.82	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	51.85	12.71	20.59	5.59	1.27	1.78
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	20.90	11.74	11.35	1.79	0.60	1.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	16.79	6.01	11.71	1.08	0.15	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	19.64	5.93	11.46	0.82	0.20	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	16.27	7.20	6.88	2.19	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	12.15	6.50	5.09	0.85	0.00	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	20.29	12.91	6.92	2.77	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	4.95	7.42	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.79	6.58	5.80	1.93	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	1.60	6.42	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	13.91	1.74	3.48	6.96	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	12.69	1.95	4.23	2.28	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	10.30	4.53	4.12	1.24	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	6.66	16.66	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.07	4.47	5.59	1.96	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	7.84	2.29	4.58	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	11.74	9.23	5.87	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	8.59	3.18	4.45	2.54	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	9.51	5.09	4.42	0.68	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	4.18	4.18	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	6.30	5.15	6.87	0.00	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	8.88	4.14	3.55	2.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	5.08	3.39	5.08	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	13.25	2.90	8.28	1.66	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	8.98	2.30	4.60	1.61	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	0.00	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	8.84	3.84	3.84	1.92	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.06	3.91	2.93	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	13.38	4.01	4.68	2.01	2.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	12.33	2.70	2.70	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	16.09	2.40	8.22	2.74	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	0.00	2.48	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.91	3.77	8.97	2.36	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	6.03	2.41	3.02	2.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	15.26	3.05	5.60	2.03	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	14.76	5.98	5.18	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	13.81	4.44	2.96	2.96	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	8.26	3.54	5.90	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	18.09	2.33	3.50	3.50	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	15.80	5.71	4.39	3.51	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	20.34	1.70	6.78	0.85	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.13	7.16	5.97	2.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.19	3.88	3.88	0.97	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	3.42	2.28	1.14	3.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.48	0.83	1.66	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	6.75	1.12	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	3.49	1.59	0.95	0.32	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.09	1.25	1.25	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	3.71	2.20	0.93	0.35	0.23	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	3.88	3.54	2.36	0.84	0.00	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	4.32	2.05	0.68	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	4.70	3.50	2.30	0.87	0.44	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.74	3.87	1.72	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	4.31	2.80	1.08	1.51	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	2.74	2.74	0.62	0.87	0.37	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	4.97	2.40	0.86	0.51	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	3.84	2.24	0.32	0.96	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	14.55	7.83	2.80	2.24	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.52	3.46	3.03	0.43	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	0.00	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.23	2.82	3.17	1.06	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	0.73	2.91	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4.55	2.62	1.05	0.87	0.17	0.17
Hepatocyte, donor1	11523-119I2	8.47	3.63	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	11.85	3.23	1.08	2.15	1.08	0.00
Hepatocyte, donor3	11684-122I1	6.14	0.00	3.07	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	2.61	3.26	5.87	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	26.39	5.42	3.50	3.15	0.35	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	14.68	4.53	3.57	2.61	0.69	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	9.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	4.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	3.25	3.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	3.97	3.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	9.98	4.43	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	4.41	0.63	3.78	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	3.09	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	6.46	1.29	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1.61	3.22	1.61	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.89	2.44	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.68	2.10	2.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	6.43	2.41	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	2.77	3.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	0.47	1.89	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	0.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	1.08	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	2.54	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.10	1.91	2.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	7.29	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.86	3.57	2.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.56	3.40	0.93	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	12.29	12.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.74	4.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	4.43	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	3.24	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	7.85	4.36	2.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	18.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	1.07	2.13	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	5.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	8.55	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	1.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	3.03	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	4.23	1.06	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	4.08	1.88	1.14	0.49	0.08	0.00
Keratinocyte - epidermal, donor2	11349-117G8	1.17	1.76	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	2.93	2.93	0.47	0.28	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	3.41	3.86	1.48	0.11	0.23	0.11
Keratocytes, donor1	11527-119I6	27.85	8.94	2.06	1.72	0.00	0.34
Keratocytes, donor2	11607-120I5	10.55	1.17	0.00	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	16.60	5.53	3.16	2.57	0.99	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	10.99	4.40	4.40	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	10.79	4.31	3.24	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	7.84	3.69	6.11	1.04	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	18.06	6.76	6.46	1.92	0.50	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	18.14	5.10	3.56	1.07	0.24	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	9.77	4.74	1.67	0.56	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	13.85	4.72	5.19	0.94	0.47	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.68	5.91	4.84	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.92	3.78	1.26	0.63	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.01	1.83	2.91	0.54	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.18	4.10	2.87	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.57	2.02	1.77	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.32	2.53	2.96	0.99	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.89	4.35	4.75	0.79	0.40	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	10.28	3.10	2.91	0.97	0.78	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.44	1.11	2.22	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.41	3.83	2.79	0.70	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.73	4.05	3.34	0.48	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.48	1.92	2.33	0.69	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.01	5.85	3.08	2.16	1.23	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.23	2.49	3.12	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.77	2.74	2.38	0.18	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	13.16	4.61	3.62	1.32	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.86	1.76	1.76	0.00	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.24	1.24	1.99	0.50	0.75	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	11.64	7.76	1.94	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.69	2.69	2.96	1.62	1.08	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.57	2.57	3.33	1.36	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.92	3.11	4.15	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	17.59	6.49	3.14	0.84	1.26	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.87	2.56	3.76	1.20	0.00	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	2.75	4.82	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.97	4.33	3.57	0.94	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.94	2.12	2.44	0.85	0.11	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.63	5.33	1.45	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	11.25	1.65	1.98	0.66	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.95	1.73	4.09	0.62	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.07	3.33	3.33	1.85	1.11	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	9.39	2.96	3.95	0.49	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.26	2.34	2.61	0.69	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	13.51	5.47	4.50	0.32	1.29	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.65	4.56	3.65	0.00	0.91	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.80	4.20	3.08	0.98	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	10.67	2.49	3.56	1.78	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.73	2.42	1.45	0.00	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.91	1.56	1.24	0.31	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.46	3.22	3.58	1.07	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.99	3.92	3.27	0.33	0.33	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.77	1.18	0.71	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.21	6.68	4.83	1.49	0.25	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.43	1.28	1.54	0.26	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.65	4.48	3.28	1.19	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	0.00	4.53	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.04	5.37	5.37	2.30	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.88	3.71	2.97	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	16.08	2.96	5.08	0.85	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.85	6.33	4.22	0.70	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	8.41	3.74	8.41	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	7.21	1.03	3.61	0.52	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5.95	2.38	2.38	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.73	2.94	5.65	2.04	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.47	3.49	2.91	0.87	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	6.30	4.50	6.30	1.35	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	11.79	3.93	6.64	1.49	0.41	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14.38	5.14	4.62	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.53	4.23	4.59	0.71	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	4.00	4.00	0.00	1.33	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.72	7.64	4.58	3.06	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.94	3.74	4.00	1.33	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.58	3.21	7.75	1.51	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	11.66	6.14	6.14	3.68	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.86	7.34	4.89	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.20	4.79	7.29	1.25	0.62	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	8.41	5.89	5.04	0.84	0.56	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	14.42	4.12	7.21	2.06	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.06	5.23	5.81	0.58	0.29	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.37	2.39	7.17	0.90	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	10.51	2.77	5.53	2.77	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.61	9.19	8.84	2.12	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.86	3.69	7.74	0.74	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	5.76	2.30	1.15	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.43	6.52	4.22	1.54	0.77	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.93	2.26	7.93	2.26	1.70	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	15.59	4.10	4.92	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	18.08	4.52	7.68	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.21	3.59	6.46	1.44	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.96	6.72	5.23	1.49	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	15.98	4.46	7.80	1.11	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	5.17	4.74	5.17	1.29	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13.70	6.85	4.28	1.71	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.66	3.66	3.66	0.33	0.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.27	4.22	8.45	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.95	4.27	4.98	0.71	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	14.09	4.12	6.87	2.06	0.34	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	13.96	4.29	4.83	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	12.12	7.41	7.41	2.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.22	4.82	8.15	2.22	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	13.96	8.14	9.30	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	5.29	5.29	1.06	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	11.20	5.60	4.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	16.72	1.45	13.08	2.91	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	4.60	6.13	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	15.29	4.44	8.39	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	12.23	3.76	5.65	0.00	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	15.59	4.02	7.54	0.50	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	2.70	6.76	0.00	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	5.16	5.16	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.02	5.79	4.01	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.95	5.08	7.04	0.39	0.00	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	10.56	4.62	5.94	2.64	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.34	4.15	5.19	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	14.88	5.69	5.69	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	14.54	4.47	8.95	2.24	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	19.87	7.51	5.30	1.32	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	14.66	5.01	7.33	3.09	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	16.20	2.53	2.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.50	5.29	8.17	0.48	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	13.12	3.98	4.77	1.99	0.00	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	15.19	4.25	3.04	3.65	0.00	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	10.38	6.23	2.77	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	15.58	3.80	4.56	1.14	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.81	1.55	8.26	1.03	0.52	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	5.44	1.81	7.86	1.81	1.21	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	14.26	5.70	6.97	1.58	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	20.79	3.73	11.19	1.60	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	6.90	3.45	9.19	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	19.54	4.63	3.60	3.60	2.06	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	13.44	3.54	5.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.35	6.81	9.08	1.13	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	16.22	8.32	5.82	2.08	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	12.53	2.35	7.05	1.57	2.35	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.11	3.34	7.93	1.25	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	17.19	7.90	9.76	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.06	4.68	3.35	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	8.55	9.62	11.76	1.07	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.38	5.25	6.87	2.02	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	5.51	5.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	6.22	12.45	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	12.54	5.13	8.55	2.85	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.87	4.60	6.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	6.57	6.57	8.21	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.04	5.35	5.79	1.78	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	12.74	5.98	4.16	1.04	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	6.63	5.30	7.29	1.99	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	4.16	6.24	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	32.14	12.99	11.85	0.91	0.23	2.73
Macrophage - monocyte derived, donor2	11313-117C8	26.98	17.62	10.09	2.75	0.73	0.18
Macrophage - monocyte derived, donor3	11389-118C3	29.89	14.16	10.49	2.23	1.44	1.31
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	4.25	1.59	0.53	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	6.65	2.85	1.43	0.48	0.00	0.48
Mallassez-derived cells, donor3	11930-125I4	5.14	2.36	1.95	0.69	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	8.67	3.99	1.00	0.80	0.20	0.20
Mammary Epithelial Cell, donor2	11350-117G9	8.98	5.21	1.45	1.16	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	4.24	3.24	0.75	0.75	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	3.39	2.71	2.71	0.68	0.68	1.36
Mast cell, donor1	11563-120D6	4.22	4.65	4.87	0.32	0.00	0.43
Mast cell, donor2	11565-120D8	20.21	15.16	13.08	0.30	0.00	1.19
Mast cell, donor3	11566-120D9	22.51	21.61	11.93	1.58	1.13	1.13
Mast cell, donor4	11567-120E1	20.39	15.25	9.04	0.35	0.71	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	5.54	3.77	4.88	0.33	0.00	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	3.50	1.17	7.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	6.65	6.88	6.65	0.23	0.11	0.92
Mast cell, expanded, donor8	11941-126A6	3.85	5.02	2.85	0.50	0.33	0.33
Melanocyte - dark, donor1	11502-119F8	9.65	5.67	2.19	1.19	0.20	0.30
Melanocyte - dark, donor2	11582-120F7	9.69	1.04	2.42	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	70.85	22.96	20.14	6.45	1.74	1.09
Melanocyte - light, donor1	11274-116H5	47.48	11.99	9.64	3.29	1.18	0.94
Melanocyte - light, donor2	11351-117H1	43.68	13.65	8.87	3.41	1.36	0.68
Melanocyte - light, donor3	11423-118G1	20.81	10.41	1.73	3.47	2.60	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	67.79	16.35	15.10	6.98	1.77	1.56
Melanocyte, donor2 (MC+2)	12739-135I3	114.84	19.36	18.56	13.18	1.88	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	135.80	21.70	20.36	13.12	4.55	1.34
Meningeal Cells, donor1	11493-119E8	15.38	9.18	8.56	2.23	0.00	0.50
Meningeal Cells, donor2	11573-120E7	12.76	11.00	7.04	2.64	0.00	0.00
Meningeal Cells, donor3	11654-122E7	13.37	4.48	7.01	0.82	0.24	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	2.85	2.57	3.14	0.00	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.53	2.11	2.92	0.30	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	3.94	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	3.92	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.02	0.72	3.59	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	29.01	7.62	9.11	1.48	1.06	1.69
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	27.14	4.52	7.54	2.01	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	2.64	1.54	1.98	0.66	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	3.65	2.19	4.38	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	2.86	2.25	2.86	0.41	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	2.77	1.66	3.46	0.28	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.72	0.37	3.35	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	9.21	1.71	3.82	1.32	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.34	1.48	1.78	0.89	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	4.48	5.12	1.28	1.92	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	10.28	4.61	5.32	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	7.51	0.94	3.13	1.56	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.81	2.18	1.45	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	13.26	3.98	4.24	0.80	0.80	0.27
Mesothelial Cells, donor2	12156-128G5	11.01	3.00	4.00	2.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	18.36	3.83	4.77	3.32	1.52	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	71.57	40.51	17.55	4.05	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	54.67	21.43	13.30	7.14	0.74	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	55.36	15.02	7.95	4.71	3.53	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	48.40	13.83	24.20	6.91	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	48.66	18.60	12.09	4.96	0.31	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	28.00	8.71	4.77	2.07	1.24	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	62.53	20.84	16.21	4.63	0.00	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	42.04	15.77	15.27	5.51	0.50	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	54.93	11.64	15.83	4.19	1.86	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	19.47	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	29.26	9.75	9.96	4.67	1.42	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	47.12	10.69	8.71	3.56	1.58	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	0.00	25.65	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	32.74	7.08	2.65	2.65	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.39	5.70	6.08	1.52	1.52	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	57.90	15.79	10.53	5.26	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	33.32	10.61	8.28	2.97	0.85	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	48.80	17.50	10.13	1.84	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	41.73	8.35	7.45	3.28	1.49	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	43.59	16.77	10.06	5.03	3.35	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	29.86	9.28	12.29	2.01	1.76	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	22.82	9.74	7.13	4.28	1.19	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	42.02	17.69	17.14	4.42	2.21	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	29.24	11.28	9.44	2.99	1.61	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	26.71	8.83	6.31	1.47	1.68	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	30.78	11.01	16.10	2.65	0.82	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	35.83	6.87	8.58	4.29	1.29	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	26.01	9.34	7.56	3.11	1.78	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	30.96	41.27	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	23.00	7.45	11.61	2.41	0.88	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	29.91	15.72	10.14	2.03	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	62.97	31.48	39.77	6.63	3.31	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	38.87	11.96	14.40	4.89	1.36	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	29.41	10.88	10.59	2.06	0.88	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	61.06	17.45	17.45	2.18	3.27	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.26	10.57	9.61	1.44	1.92	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	29.22	10.01	10.41	2.40	1.60	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	39.77	15.08	12.34	9.60	4.11	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	25.53	3.50	8.51	3.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	18.35	12.23	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	26.28	13.58	13.14	1.75	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	61.80	60.70	14.35	4.41	5.52	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	44.83	24.33	14.09	2.56	0.00	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	26.53	8.93	8.68	1.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	51.50	28.53	8.35	6.96	2.78	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	41.99	37.57	8.84	6.63	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	15.73	8.55	6.50	1.03	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	50.76	24.51	8.75	5.25	2.19	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	31.60	17.04	9.23	2.13	0.00	1.78
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	18.24	13.47	3.93	2.52	1.40	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	43.64	22.86	6.65	2.49	1.66	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	26.22	11.07	7.58	2.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	22.62	8.75	5.43	2.41	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	25.88	14.61	1.67	2.09	0.42	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00	0.00	7.22	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	30.48	8.31	8.31	3.69	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	35.29	18.21	2.85	4.55	1.71	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	21.28	11.47	4.84	1.80	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	16.59	8.81	5.96	1.04	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	32.60	19.30	3.43	6.43	0.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	27.95	15.88	4.45	1.91	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	24.29	11.21	8.01	2.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	38.01	11.67	10.48	1.80	1.20	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.37	9.46	6.36	1.27	0.14	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	13.70	6.37	3.50	0.64	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	39.36	20.79	4.64	2.21	1.11	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	30.72	18.96	5.31	1.90	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.19	9.09	7.39	2.27	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.09	13.03	5.16	2.21	0.25	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	31.93	18.90	10.43	5.21	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	25.87	12.94	6.76	2.35	0.59	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	31.14	11.82	7.21	1.15	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	27.20	11.13	10.72	2.47	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	45.26	19.36	15.48	5.36	0.30	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	3.77	11.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	49.90	7.13	12.48	3.56	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	47.97	11.83	13.80	4.60	0.33	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	34.71	8.42	8.42	3.16	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	76.90	16.21	12.65	3.76	0.99	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	66.12	19.56	18.63	8.38	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	43.19	8.64	13.14	5.26	0.75	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	39.95	11.19	8.52	2.66	2.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	35.29	8.48	7.80	2.15	0.23	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	41.99	7.37	5.16	1.47	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	46.54	7.33	12.46	3.30	1.83	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	37.33	6.22	14.00	3.11	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	41.69	4.81	12.83	2.67	2.14	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	11.59	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	41.41	5.05	7.07	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	38.79	10.54	6.75	2.53	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	40.86	8.17	10.90	1.36	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.89	1.27	9.54	1.27	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.87	4.86	9.72	2.43	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	28.70	7.55	10.57	3.02	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	17.13	57.10	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	3.26	19.57	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	9.50	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	30.59	10.77	10.34	4.52	1.51	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	14.11	3.14	4.70	1.05	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.68	1.33	2.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.02	7.10	1.25	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	10.65	3.42	3.61	3.23	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	4.79	4.79	14.36	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.84	2.04	2.72	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	11.03	0.00	1.84	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.77	0.84	2.09	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	9.76	3.72	1.63	1.39	0.00	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.27	1.35	2.16	1.35	0.54	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	12.19	2.52	2.31	3.15	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.47	1.49	1.49	0.50	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.85	0.81	2.98	2.17	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.39	2.27	2.72	0.68	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.65	2.45	3.43	1.63	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	8.75	2.19	1.46	2.92	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.08	1.06	3.71	1.59	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.80	2.40	1.80	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	8.86	1.64	3.61	1.64	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.68	2.28	2.93	2.93	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	10.76	2.12	5.29	4.59	0.88	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	2.11	4.92	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	7.36	0.92	3.22	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.32	1.93	3.53	3.86	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	10.69	2.41	6.21	3.10	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	42.98	2.53	10.11	7.59	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.36	1.34	4.90	4.46	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.97	2.54	2.54	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	5.93	1.42	3.80	1.42	0.47	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	5.58	2.15	3.43	3.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	27.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	20.99	4.00	4.67	4.33	1.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	14.88	2.25	6.76	3.16	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.92	2.78	2.78	3.97	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	3.71	1.86	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.62	4.54	9.84	5.30	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.06	3.26	6.52	2.28	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.28	3.49	6.10	1.74	1.31	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	16.73	2.71	6.33	4.52	1.36	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	1.76	4.41	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	0.00	1.99	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.91	4.96	6.45	5.46	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.78	3.83	9.95	2.68	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	8.77	3.33	3.33	1.21	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.69	1.99	6.19	3.54	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.26	2.03	4.74	2.71	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.19	1.83	9.75	1.83	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.05	7.24	7.24	4.41	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.17	1.82	3.33	2.42	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	19.78	3.16	9.49	4.75	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	17.00	1.13	7.94	9.07	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	5.06	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	7.33	4.35	5.84	0.50	0.37	0.62
Myoblast, donor2	11322-117D8	3.64	2.88	4.22	0.58	0.00	0.00
Myoblast, donor3	11398-118D3	6.56	3.87	2.35	1.01	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	13.43	7.15	1.31	1.17	0.73	1.17
Natural Killer Cells, donor1	11230-116C6	60.58	15.07	21.22	2.15	0.31	3.08
Natural Killer Cells, donor2	11311-117C6	53.07	13.57	25.63	3.02	0.60	1.81
Natural Killer Cells, donor3	11387-118C1	52.46	20.06	15.28	2.94	0.74	1.66
Neural stem cells, donor1	11275-116H6	2.54	0.36	1.09	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	1.93	0.00	5.78	0.00	0.00	1.93
Neurons, donor1	11494-119E9	2.28	0.00	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	1.10	0.88	1.76	0.00	0.00	0.22
Neurons, donor3	11655-122E8	0.82	0.00	0.82	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	373.99	91.87	86.30	33.41	2.78	13.92
Neutrophils, donor2	11314-117C9	481.21	104.36	81.17	40.58	17.39	8.70
Neutrophils, donor3	11390-118C4	1009.72	189.36	188.75	46.42	8.55	22.60
Nucleus Pulposus Cell, donor1	11252-116F1	1.90	0.83	1.90	0.00	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	0.33	0.98	0.98	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	1.00	1.80	0.80	0.00	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	28.49	5.78	7.85	3.58	1.93	0.00
Olfactory epithelial cells, donor2	11934-125I8	17.37	3.04	4.34	2.17	0.58	0.58
Olfactory epithelial cells, donor3	11935-125I9	22.59	2.61	4.43	3.63	1.48	0.23
Olfactory epithelial cells, donor4	11936-126A1	16.27	4.19	5.65	2.53	0.29	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	48.15	9.03	5.42	6.02	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	5.32	2.55	5.74	0.00	0.21	0.64
Osteoblast - differentiated, donor2	11353-117H3	8.00	2.29	6.86	0.00	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	6.21	2.48	0.62	2.48	0.00	0.00
Osteoblast, donor1	11277-116H8	3.71	1.56	2.35	0.59	0.00	0.59
Osteoblast, donor2	11354-117H4	9.13	4.92	4.92	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	6.40	3.91	4.80	1.07	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	13.98	5.39	5.05	1.68	0.42	0.76
Pericytes, donor1	11491-119E6	3.67	1.67	1.45	0.22	0.11	0.11
Pericytes, donor2	11571-120E5	3.40	3.17	4.30	1.13	0.00	0.00
Pericytes, donor3	11652-122E5	4.07	1.83	1.83	1.02	0.20	0.00
Perineurial Cells, donor1	11499-119F5	3.96	2.71	2.03	0.57	0.00	0.23
Perineurial Cells, donor2	11579-120F4	9.29	3.77	2.02	0.64	0.28	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	99.77	17.21	28.37	6.37	1.27	2.55
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	65.38	15.43	18.85	4.65	1.22	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	83.08	18.25	21.87	5.05	0.91	1.04
Placental Epithelial Cells, donor1	11278-116H9	1.91	0.72	0.24	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	4.44	2.22	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	1.77	0.79	0.79	0.39	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.48	2.22	4.11	2.22	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	10.88	1.50	3.75	0.94	0.00	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	5.74	2.48	2.35	0.52	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	6.30	2.93	4.28	0.90	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	7.78	2.02	7.35	1.49	0.00	0.43
Preadipocyte - omental, donor2	11329-117E6	26.19	5.67	7.86	2.18	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	6.73	3.01	3.72	0.72	0.43	0.57
Preadipocyte - perirenal, donor1	11469-119C2	1.97	1.97	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	4.91	1.54	3.07	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	8.85	5.67	2.83	1.24	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	3.07	3.07	2.21	0.17	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	11.83	4.66	2.98	0.75	0.28	0.28
Preadipocyte - visceral, donor2	11357-117H7	12.89	5.06	2.30	1.38	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	5.22	3.76	1.67	0.94	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	23.08	4.68	4.98	3.32	1.21	0.00
Prostate Epithelial Cells, donor2	11331-117E8	2.71	1.22	1.62	0.27	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	4.35	2.88	0.86	0.67	0.12	0.12
Prostate Stromal Cells, donor1	11254-116F3	12.53	3.76	3.19	1.59	0.34	0.46
Prostate Stromal Cells, donor2	11332-117E9	19.90	4.12	5.92	3.23	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	12.41	3.96	4.38	2.82	0.31	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.12	2.55	2.19	0.36	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	7.42	4.02	3.33	0.62	0.14	0.28
Renal Epithelial Cells, donor1	11517-119H5	3.55	3.04	1.01	0.51	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.13	5.69	1.42	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	5.82	3.28	3.49	0.53	0.00	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	15.66	3.40	0.68	2.72	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	27.76	9.03	3.91	4.99	0.81	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	19.31	6.88	3.55	2.44	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	2.00	2.00	2.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	5.72	4.18	3.52	0.44	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	5.02	0.00	3.13	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.66	0.83	1.39	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	13.42	9.13	4.29	1.34	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	7.17	3.80	3.37	0.84	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.56	4.44	1.93	0.58	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	15.56	6.22	1.81	4.93	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.35	3.13	5.12	1.71	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	10.29	4.12	2.06	4.12	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.53	2.51	2.51	0.75	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	34.88	7.48	8.95	3.74	1.47	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	20.55	4.47	7.15	1.79	2.68	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	3.30	0.00	4.40	0.00	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.60	1.16	5.22	1.16	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	8.45	6.63	7.15	1.17	0.00	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	6.55	3.87	4.27	0.79	0.10	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	8.25	4.91	6.13	1.00	0.45	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	7.69	6.33	2.85	1.12	0.25	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	6.06	2.80	4.20	0.70	0.58	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	8.32	3.24	4.62	0.69	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	7.80	6.02	4.24	0.82	0.41	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	7.87	2.72	3.33	1.36	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.57	5.38	6.09	1.25	0.54	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	5.16	5.88	3.44	0.72	0.29	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	6.22	4.94	3.97	1.18	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	6.20	4.20	4.65	1.99	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	8.22	6.31	5.54	1.53	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	7.64	6.06	3.91	0.84	0.19	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	10.52	5.64	6.20	0.75	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	9.29	5.57	5.57	1.33	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	5.65	4.58	2.34	0.88	0.19	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	7.64	4.58	3.82	1.34	0.19	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	7.37	5.45	4.38	1.17	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	8.13	5.05	2.80	0.84	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	7.35	4.27	5.30	1.71	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	8.39	6.75	7.29	0.91	0.55	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	6.01	3.80	3.68	0.74	0.37	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	8.73	4.30	3.63	1.34	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	4.95	4.48	6.60	0.94	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	5.75	2.78	3.17	0.79	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	10.52	5.38	4.68	0.94	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	6.84	3.94	5.81	1.45	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.75	3.32	5.53	0.66	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	7.94	3.34	4.18	2.09	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	7.27	4.71	5.25	1.35	0.67	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	8.51	5.45	5.45	1.02	0.51	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	8.87	6.94	5.01	1.74	0.00	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	7.91	2.92	5.33	0.69	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	7.00	4.53	5.08	0.96	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	10.01	3.45	3.61	0.66	0.16	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.03	5.45	3.75	0.85	0.34	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	7.10	5.18	4.59	1.18	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	10.40	4.26	4.53	0.80	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.60	4.56	5.81	0.97	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	8.10	2.86	3.33	1.90	0.24	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	16.53	10.08	5.84	3.63	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	9.23	2.92	3.30	1.60	0.19	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	7.34	5.59	3.49	1.75	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	15.11	3.93	6.04	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.42	4.90	3.18	1.47	0.49	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	17.32	4.66	9.90	1.75	0.15	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	15.82	4.26	4.26	1.83	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.04	3.92	2.71	0.30	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	9.27	4.52	4.75	1.36	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	16.47	3.59	5.69	3.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.79	4.84	5.55	1.42	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	9.39	2.77	3.84	1.92	0.43	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	24.04	6.61	4.21	3.61	0.00	0.00
Schwann Cells, donor1	11498-119F4	3.39	2.26	1.50	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	3.51	1.31	2.85	0.44	0.00	0.22
Sebocyte, donor1	11220-116B5	5.48	2.19	3.83	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	1.38	1.38	0.92	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	2.47	1.65	0.62	0.62	0.00	0.41
Sertoli Cells, donor1	11255-116F4	8.28	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.74	4.13	4.84	0.97	0.44	0.35
Skeletal Muscle Cells, donor2	11358-117H8	13.73	2.17	2.89	2.17	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	2.51	1.67	1.67	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	3.77	4.71	1.89	0.31	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	3.86	4.01	1.93	0.74	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	6.16	5.39	3.39	1.23	0.46	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	4.79	2.65	2.52	0.38	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	3.28	2.57	2.28	0.43	0.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	8.14	4.66	3.17	0.69	0.50	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	9.27	1.60	5.90	1.85	0.76	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	2.17	2.90	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.58	1.79	1.79	0.96	0.14	0.28
Skin - palm, donor1	10286-104F7	16.12	5.37	0.00	5.37	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.03	1.87	1.59	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	6.54	2.45	4.91	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	1.69	1.69	1.82	0.52	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	3.06	0.97	0.83	0.42	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	2.95	2.25	1.55	0.56	0.14	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	5.71	5.50	1.06	0.00	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	5.85	3.75	1.05	0.97	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1.85	2.16	0.62	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2.45	0.89	0.89	0.00	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.34	5.29	3.53	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	9.06	3.31	3.09	1.33	0.00	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.30	3.15	2.36	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	9.27	6.95	3.09	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	2.00	0.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.58	5.19	7.05	1.46	0.67	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	5.32	2.22	2.66	1.77	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	26.37	8.45	8.96	6.53	1.79	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.77	3.91	3.91	0.98	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	17.13	4.73	5.61	2.95	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.51	4.13	4.70	2.85	0.43	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	10.09	4.23	2.44	1.14	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.66	3.04	6.39	1.22	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	4.29	1.26	4.29	0.00	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.87	4.77	3.34	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	15.04	3.69	3.83	1.77	0.44	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.33	3.01	3.44	1.51	0.22	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.81	3.67	1.99	1.99	0.63	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.13	3.40	4.18	0.77	0.31	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	2.16	3.23	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	6.57	3.59	2.99	0.60	0.60	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.10	2.05	2.05	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	8.87	2.59	3.53	1.33	0.08	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	16.71	4.03	7.04	3.52	1.11	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	10.92	2.96	1.82	2.05	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.83	2.42	2.42	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	14.57	4.77	5.30	1.06	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.31	5.99	5.59	2.40	1.33	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	6.39	1.88	1.88	0.88	0.13	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.37	1.27	2.03	0.00	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	12.36	3.77	3.47	1.51	0.30	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.00	0.00	3.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	18.09	5.17	1.29	3.88	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	3.26	0.93	1.86	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.59	1.51	2.02	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.40	2.19	4.39	1.25	0.94	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	10.32	5.60	2.06	0.29	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	9.50	4.92	3.08	0.50	0.17	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	11.21	2.80	4.67	1.87	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	22.88	6.19	6.04	2.45	1.30	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	21.93	5.61	2.55	2.29	1.02	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	13.35	4.89	2.44	1.13	0.94	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	8.94	5.59	4.19	0.98	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	6.12	2.60	3.60	0.50	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	1.90	0.95	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	18.10	3.67	9.05	2.94	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	19.89	5.74	9.50	5.08	1.99	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.41	7.61	0.88	1.76	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	11.66	1.55	4.28	0.19	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	19.31	3.17	4.50	2.64	1.06	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.07	1.49	1.49	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	36.65	5.03	7.55	3.95	1.44	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	28.39	5.68	6.53	4.26	2.27	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	11.42	2.36	4.73	1.97	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.89	2.29	4.32	1.52	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	14.77	3.19	6.79	1.60	0.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	3.34	7.52	2.93	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	5.04	2.29	2.29	1.38	0.46	0.00
Synoviocyte, donor1	11291-117A4	32.82	3.70	13.97	4.21	0.84	0.84
Synoviocyte, donor2	11368-117I9	2.68	0.50	1.84	0.34	0.00	0.00
Synoviocyte, donor3	11440-118H9	1.12	0.89	1.79	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	16.79	7.50	1.79	1.43	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	0.00	1.98	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.87	2.55	1.39	0.93	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	3.37	2.94	0.43	0.07	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	3.09	1.93	1.16	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	1.72	1.72	0.00	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	31.25	11.32	10.83	4.55	0.98	0.98
Urethra, donor2	10319-105A4	66.54	5.40	5.40	25.18	8.99	0.00
Urothelial Cells, donor1	11520-119H8	2.39	2.13	1.59	0.00	0.00	0.53
Urothelial Cells, donor2	11600-120H7	0.40	1.20	0.00	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	0.69	0.69	0.69	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	2.90	3.12	1.78	0.22	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	203.76	53.39	72.96	9.79	0.89	5.34
Whole blood (ribopure), donor090309, donation2	12180-129A2	214.44	55.75	62.90	17.16	2.86	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	193.72	32.86	39.02	14.37	0.68	6.16
Whole blood (ribopure), donor090325, donation1	12176-128I7	153.57	29.96	49.58	4.48	2.07	8.95
Whole blood (ribopure), donor090325, donation2	12177-128I8	177.21	30.21	45.90	9.88	0.58	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	215.54	65.60	51.02	9.37	1.04	12.49
Whole blood (ribopure), donor090612, donation2	12183-129A5	192.74	61.49	36.71	16.52	1.84	5.51
Whole blood (ribopure), donor090612, donation3	12184-129A6	141.50	27.39	39.25	9.13	0.91	5.48
Wilms' tumor cell line:G-401	10809-111A8	12.71	3.95	2.22	1.36	0.99	0.00
Wilms' tumor cell line:HFWT	10597-108E3	4.40	8.80	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	8.66	5.03	1.12	0.28	0.00	0.00
achilles tendon, donor2	10292-104G4	37.20	4.13	8.27	4.13	8.27	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	35.95	9.43	4.08	3.06	0.25	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	21.13	16.02	3.48	2.79	1.16	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	12.35	8.78	2.02	0.47	0.36	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	7.07	13.61	4.08	0.00	0.00	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	7.87	4.22	1.97	0.84	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	20.73	11.42	6.56	0.42	0.42	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	39.74	13.07	12.52	4.90	0.82	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	25.12	7.49	6.17	1.32	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	10.21	6.13	6.53	2.45	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	47.76	15.92	6.99	3.88	4.66	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	5.34	6.26	3.13	0.55	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	35.10	11.70	15.60	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	14.87	9.06	2.79	1.63	0.70	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	6.21	6.21	5.18	1.04	0.00	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	4.09	4.97	7.89	0.00	0.29	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	13.48	7.44	3.72	0.46	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	9.46	7.40	4.94	2.88	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	4.91	6.14	5.83	0.00	0.00	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	5.12	4.27	4.27	0.43	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	4.25	5.16	4.85	0.30	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	5.54	4.57	5.05	0.00	0.24	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	7.80	4.23	2.45	0.45	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	10.01	5.67	2.33	1.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	9.29	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	14.69	7.53	3.01	0.75	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	9.59	12.65	4.80	1.31	0.00	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	29.99	11.25	3.75	1.87	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	25.67	8.95	0.94	2.59	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	42.19	14.27	19.39	3.26	0.62	1.86
adipose, donor1	10184-103D4	6.45	5.28	6.45	1.17	0.00	0.00
adipose, donor2	10185-103D5	5.27	2.43	2.84	0.41	0.00	0.00
adipose, donor3	10186-103D6	7.62	4.08	4.08	1.36	0.27	0.27
adipose, donor4	10187-103D7	13.00	3.47	9.53	1.73	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	11.05	12.15	3.00	3.16	0.16	0.32
adrenal gland, adult, pool1	10081-102A9	18.19	7.28	7.28	10.91	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	33.08	16.01	3.07	2.80	0.80	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	10.36	3.22	2.14	1.43	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	32.23	16.23	3.25	1.85	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	20.96	10.82	5.41	2.03	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	22.10	9.43	2.65	1.77	0.29	0.29
amygdala - adult, donor10196	10167-103B5	2.37	0.00	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	6.29	3.85	2.03	1.01	0.20	0.41
amygdala, newborn, donor10223	10360-105E9	6.46	0.97	8.07	1.29	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	13.88	4.71	4.58	2.29	0.38	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	10.15	5.96	2.43	0.44	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	17.37	7.68	13.03	2.34	0.00	0.33
aorta, adult, pool1	10052-101G7	226.14	29.22	34.91	47.27	16.48	1.57
appendix, adult	10189-103D9	68.70	15.14	21.35	15.14	2.72	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1.03	1.03	0.34	0.00	0.00	0.00
artery, adult	10190-103E1	39.40	13.59	6.79	5.43	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	2.90	1.59	2.90	0.58	0.00	0.14
b cell line:RPMI1788	10427-106D4	30.78	20.97	7.14	1.49	1.49	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	36.07	8.32	13.04	3.61	1.11	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	11.71	6.65	2.78	1.29	0.10	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	5.86	3.85	2.01	0.17	0.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	9.51	5.03	4.47	1.12	0.56	0.56
bladder, adult, pool1	10011-101C2	125.05	22.49	18.36	35.20	7.17	1.63
blood, adult, pool1	10053-101G8	84.16	26.58	11.07	11.07	0.00	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	10.28	2.57	3.43	0.86	0.00	0.00
bone marrow, adult	10192-103E3	18.90	5.40	17.55	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	11.28	2.05	3.08	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	4.79	2.56	3.56	0.56	0.11	0.78
brain, fetal, pool1	10085-102B4	2.67	0.00	5.34	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	13.88	7.27	7.93	2.31	0.00	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	12.86	5.24	5.74	0.62	0.25	0.25
breast, adult, donor1	10080-102A8	83.97	21.47	12.63	22.10	3.79	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	3.68	4.32	1.40	0.64	0.13	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	15.46	7.73	3.71	0.31	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.76	3.22	0.69	1.15	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.17	4.36	1.45	0.48	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	0.47	7.05	0.94	0.47	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	54.80	13.67	6.02	4.38	1.42	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	3.49	5.39	2.85	0.32	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	10.91	5.59	1.33	0.80	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	13.82	3.45	1.15	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	3.68	1.34	2.68	0.50	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	2.29	2.29	3.82	0.76	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	4.76	0.37	3.30	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	5.83	0.00	2.91	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	6.19	2.14	8.54	0.85	0.00	0.43
cerebellum, adult, pool1	10083-102B2	4.83	2.41	3.10	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	2.49	0.00	1.66	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	17.90	2.52	5.55	2.02	0.25	0.50
cerebrospinal fluid, donor2	10294-104G6	21.93	2.19	5.12	5.85	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	4.31	2.30	0.86	0.58	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	5.63	2.32	0.83	0.50	0.50	0.17
cervix, adult, pool1	10013-101C4	44.62	11.44	10.50	5.67	1.68	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	7.38	2.23	2.23	0.42	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	1.31	1.31	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	29.58	17.27	10.19	3.36	0.99	0.87
choriocarcinoma cell line:SCH	10785-110H2	3.94	4.19	2.22	0.12	0.37	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	7.83	8.30	2.61	1.19	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	15.96	11.68	2.56	2.56	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	19.09	6.26	4.08	2.49	0.30	0.10
chorionic membrane cells, donor3	12240-129G8	15.94	7.69	4.95	1.65	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	16.16	5.05	2.02	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	10.57	8.07	4.42	0.38	0.77	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	14.99	8.45	2.53	1.48	0.00	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	12.58	7.19	2.82	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	14.51	6.53	1.94	0.73	0.97	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	13.23	6.92	1.63	0.41	0.41	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	8.54	8.83	0.88	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	9.90	5.21	4.17	0.78	0.00	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	5.94	11.89	3.20	0.69	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	14.05	7.63	4.16	1.39	0.17	0.52
colon carcinoma cell line:CACO-2	10513-107D9	15.56	7.87	0.92	1.10	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	36.87	15.96	7.60	6.08	0.00	0.00
colon, adult, donor1	10082-102B1	110.67	10.71	9.52	22.61	9.52	2.38
colon, adult, pool1	10014-101C5	59.93	10.69	8.46	9.52	3.41	0.94
colon, fetal, donor1	10070-101I7	97.64	16.69	7.42	41.41	10.51	1.24
common myeloid progenitor CMP, donor1	12130-128D6	32.08	41.25	27.50	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	28.47	10.20	12.75	3.40	1.27	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	20.68	12.98	6.64	1.21	0.75	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	24.82	11.14	6.35	1.13	1.13	0.42
corpus callosum, adult, pool1	10042-101F6	16.14	7.52	10.95	1.66	0.33	0.55
cruciate ligament, donor2	10295-104G7	61.60	8.10	7.29	16.21	0.81	1.62
diaphragm, fetal, donor1	10069-101I6	17.66	7.22	4.82	1.61	0.80	1.61
diencephalon, adult	10193-103E4	12.24	6.00	6.48	2.64	0.48	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	25.03	11.25	4.36	2.98	0.92	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	4.10	4.62	3.08	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.37	5.78	0.96	1.44	0.96	0.00
ductus deferens, adult	10196-103E7	53.82	8.97	5.98	19.93	2.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	5.76	4.32	10.08	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	34.58	4.41	7.36	5.15	4.41	0.74
dura mater, adult, donor1	10041-101F5	16.35	8.09	14.87	1.40	0.66	2.15
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	11.77	2.00	3.55	0.44	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.19	2.15	5.30	1.86	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	25.28	13.57	3.70	3.08	3.08	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	36.33	11.20	3.33	4.24	2.72	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	24.70	11.73	2.47	3.09	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	49.91	21.02	3.94	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	13.07	8.72	3.35	1.01	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	24.65	12.32	5.26	5.26	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.33	4.66	4.02	1.61	0.32	0.48
epidermoid carcinoma cell line:A431	10426-106D3	11.34	6.45	2.33	0.78	0.11	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	8.91	5.17	2.09	0.77	0.66	0.22
epididymis, adult	10197-103E8	28.88	7.95	9.63	4.60	1.05	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	1.06	1.77	0.53	0.00	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	23.99	5.51	6.29	4.33	1.97	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	14.28	3.93	1.18	1.05	0.13	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	13.68	4.53	1.48	2.36	0.79	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	17.36	5.49	2.24	2.24	0.56	0.11
esophagus, adult, pool1	10015-101C6	60.20	10.30	9.13	13.27	3.82	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	16.91	4.38	6.01	2.25	1.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	12.07	2.41	0.00	7.24	2.41	4.83
eye - muscle lateral, donor2	10298-104H1	25.25	6.31	0.00	8.42	0.00	0.00
eye - muscle medial, donor2	10299-104H2	23.81	8.93	0.00	16.37	5.95	1.49
eye - muscle superior, donor2	10297-104G9	40.13	6.88	17.20	11.46	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	21.86	8.74	10.20	2.91	1.46	0.00
eye, fetal, donor1	10054-101G9	21.10	3.81	3.05	5.08	1.78	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	7.44	5.51	1.92	0.64	0.38	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	14.96	10.92	1.19	2.37	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	8.82	4.13	5.82	1.03	0.28	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	7.51	5.40	3.30	0.60	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	8.78	4.75	1.65	0.82	0.09	0.00
gall bladder, adult	10198-103E9	76.78	10.14	13.52	13.76	3.62	1.21
gamma delta positive T cells, donor1	11937-126A2	87.51	26.84	19.33	4.29	1.61	2.68
gamma delta positive T cells, donor2	11938-126A3	64.61	20.17	22.41	1.87	0.37	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	4.86	1.90	0.21	0.42	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	19.73	14.12	0.19	2.51	0.77	0.39
gastric cancer cell line:AZ521	10549-107H9	8.20	5.25	1.80	0.82	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	14.64	9.15	2.75	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	7.77	1.83	1.37	2.06	0.46	0.00
giant cell carcinoma cell line:LU65	10487-107B1	4.82	2.07	0.46	0.69	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	16.80	6.58	2.94	2.24	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	4.99	2.49	0.50	0.25	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	11.93	3.06	1.06	0.84	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	13.34	4.92	1.83	0.84	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	12.58	3.53	1.66	0.88	0.11	0.22
glioma cell line:GI-1	10413-106B8	2.34	1.76	1.46	1.17	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	8.02	2.19	2.19	1.46	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	14.65	7.32	7.08	1.71	0.49	0.24
globus pallidus, adult, donor10258	10367-105F7	8.22	6.85	4.11	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	6.40	0.53	4.26	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	80.76	85.65	48.94	0.00	0.00	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	21.44	6.40	6.40	2.24	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	16.99	9.18	8.72	3.21	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	21.95	3.20	7.77	2.29	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	24.48	12.88	8.37	2.58	0.64	0.64
hIPS, biol_rep1	14380-156B6	33.06	4.31	7.19	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	19.89	8.92	12.35	2.06	0.69	1.37
hIPS, biol_rep3	14382-156B8	9.93	4.41	1.10	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	6.90	5.75	4.02	0.29	0.00	0.57
heart - mitral valve, adult	10205-103F7	58.60	9.57	14.35	14.65	2.39	0.60
heart - pulmonic valve, adult	10206-103F8	157.93	11.77	19.35	41.31	14.64	0.52
heart - tricuspid valve, adult	10207-103F9	29.14	9.99	17.49	8.33	1.67	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	42.24	10.20	4.29	11.63	2.24	1.02
heart, adult, diseased, donor1	10051-101G6	83.46	8.09	6.81	24.27	2.55	0.43
heart, adult, pool1	10016-101C7	97.28	17.94	10.12	14.72	1.38	1.61
heart, fetal, pool1	10046-101G1	70.44	12.12	24.85	10.88	2.77	1.33
hepatic mesenchymal tumor cell line:LI90	10778-110G4	21.29	7.71	7.40	3.70	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	4.76	4.76	0.00	3.57	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	16.80	6.52	3.20	0.99	0.33	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	14.93	8.50	1.70	1.46	0.61	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	16.17	8.49	3.13	1.72	0.40	0.30
hepatoma cell line:Li-7	10484-107A7	30.36	3.45	1.45	3.45	1.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	13.67	10.85	1.71	1.81	0.10	0.10
hippocampus - adult, donor10196	10169-103B7	2.84	2.84	3.79	2.84	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	9.18	4.69	8.37	1.22	0.20	0.61
hippocampus, adult, donor10258	10374-105G5	5.98	1.99	5.98	0.50	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	3.17	0.70	2.47	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	14.04	5.49	19.53	1.22	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	12.96	5.89	15.71	0.79	0.00	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	14.73	5.59	14.47	1.02	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.64	3.95	7.89	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	6.97	4.39	6.71	0.77	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	6.83	2.66	9.11	0.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	5.26	1.75	3.50	0.29	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	6.46	3.45	3.66	1.08	0.22	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	9.18	1.25	5.42	1.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	4.74	2.84	3.08	0.71	0.24	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	4.66	1.61	3.70	0.32	0.00	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	5.39	1.35	6.06	0.00	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	12.52	8.29	10.80	1.72	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	11.30	8.35	8.35	1.47	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	10.47	5.24	20.07	2.62	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	5.35	3.63	6.68	0.38	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	5.67	3.05	5.67	1.31	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	8.00	3.00	8.00	0.50	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1.51	1.32	1.32	0.19	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	3.18	2.73	3.18	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	4.07	2.51	1.88	0.00	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	2.78	1.31	3.27	0.16	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	2.90	0.87	2.90	0.00	0.00	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	3.59	1.20	4.78	0.60	0.00	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.59	5.54	11.27	2.40	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	16.26	8.84	11.98	2.57	0.86	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	16.33	6.94	13.88	4.08	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	8.10	3.87	5.63	1.76	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.97	3.80	5.38	0.63	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6.66	3.33	5.14	1.21	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	10.34	3.10	2.59	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.30	3.32	1.99	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.95	1.54	3.59	1.28	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	3.07	2.81	4.60	0.51	0.00	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	9.84	1.51	1.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	7.39	1.34	4.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.52	8.69	9.18	0.48	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	16.94	6.68	12.48	1.78	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	11.71	9.76	8.78	2.44	0.00	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	6.11	3.06	3.97	1.22	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	16.27	3.25	6.51	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	6.62	1.99	6.62	0.66	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1.64	0.55	2.19	0.55	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	5.07	2.53	2.53	0.72	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	4.27	0.71	1.78	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	2.39	2.39	2.39	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	4.20	2.17	4.60	0.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	3.50	1.35	4.31	1.89	0.00	0.54
immature langerhans cells, donor1	11904-125F5	33.42	16.22	11.87	1.70	1.21	0.00
immature langerhans cells, donor2	11905-125F6	6.34	5.54	4.75	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	10.22	4.16	6.91	0.85	0.19	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	2.60	0.65	0.98	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	12.92	4.31	4.91	1.80	0.40	0.30
kidney, fetal, pool1	10045-101F9	7.57	4.10	8.49	1.13	0.07	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	26.70	12.50	7.24	2.70	0.00	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.10	3.32	1.11	1.38	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	6.79	4.59	0.92	0.73	0.18	0.00
left atrium, adult, donor1	10079-102A7	86.63	10.90	11.99	23.43	3.81	1.09
left ventricle, adult, donor1	10078-102A6	54.11	12.64	8.60	14.16	3.54	0.51
leiomyoblastoma cell line:G-402	10721-110A1	9.85	3.56	0.55	1.37	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	26.58	4.31	2.87	5.03	2.51	0.36
leiomyoma cell line:15242A	10570-108B3	18.48	1.63	1.63	2.17	7.61	0.00
leiomyoma cell line:15425	10571-108B4	17.97	3.64	1.94	2.19	2.19	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	14.64	4.18	9.41	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	6.02	6.26	2.48	0.47	0.12	0.35
liposarcoma cell line:KMLS-1	10782-110G8	2.97	1.72	1.25	0.00	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	27.66	6.94	2.19	3.53	1.22	0.00
liver, adult, pool1	10018-101C9	11.99	2.11	4.54	1.30	0.00	0.49
liver, fetal, pool1	10086-102B5	14.11	2.82	2.82	0.00	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	4.96	1.17	3.21	1.17	0.00	0.44
locus coeruleus, adult, donor10252	10165-103B3	6.64	2.77	2.95	0.55	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	6.21	2.26	3.67	1.13	0.00	0.56
locus coeruleus, newborn, donor10223	10362-105F2	3.79	0.84	2.52	0.84	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	17.16	9.41	1.52	1.94	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	26.20	10.34	2.07	1.38	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	78.96	41.79	15.55	11.73	1.05	1.19
lung, adult, pool1	10019-101D1	53.75	17.36	13.94	5.08	1.54	1.42
lung, fetal, donor1	10068-101I5	36.82	9.99	11.70	6.28	1.14	1.14
lung, right lower lobe, adult, donor1	10075-102A3	49.49	12.37	12.83	15.12	1.83	1.83
lymph node, adult, donor1	10077-102A5	33.14	17.04	16.09	1.89	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	2.63	3.51	1.32	0.66	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	83.92	29.88	10.87	7.24	1.66	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	19.54	2.55	2.55	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	79.47	17.32	25.75	10.66	0.89	1.33
mature adipocyte, donor2	12232-129F9	89.03	13.49	22.41	5.40	1.66	2.49
mature adipocyte, donor3	12233-129G1	69.22	17.31	18.97	6.87	1.19	1.66
mature adipocyte, donor4	12234-129G2	47.38	10.53	15.27	6.05	0.00	2.11
maxillary sinus tumor cell line:HSQ-89	10414-106B9	13.82	8.82	3.34	1.43	0.24	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	2.26	3.38	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	6.99	2.39	3.49	0.55	0.18	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	4.77	3.49	4.13	0.00	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	6.82	1.71	8.96	1.28	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	3.04	1.01	3.21	1.35	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	4.88	4.24	4.03	1.27	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	1.93	5.78	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.90	1.08	11.49	1.44	0.00	0.72
medulla oblongata - adult, donor10196	10174-103C3	31.15	5.84	4.54	3.89	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	21.36	5.88	8.05	1.86	0.15	0.31
medulla oblongata, adult, pool1	10038-101F2	14.69	5.22	8.65	1.22	0.24	0.73
medulla oblongata, newborn, donor10223	10361-105F1	4.17	1.04	3.47	0.00	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	19.04	8.41	3.32	1.99	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	4.28	2.32	0.49	0.37	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	56.78	10.35	3.16	5.17	1.87	0.14
melanoma cell line:G-361	10465-106H6	31.22	8.14	5.16	2.17	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	6.87	2.17	1.45	1.09	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	24.67	14.98	9.69	5.29	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	15.55	9.59	5.44	2.59	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	3.53	1.69	1.07	0.61	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	3.64	0.55	0.55	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	2.48	0.41	1.24	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.78	2.81	2.53	0.56	0.28	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	3.85	0.96	2.50	0.39	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	3.47	2.08	4.86	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.44	3.26	2.57	0.34	0.51	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	5.98	2.42	4.37	0.69	0.00	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	4.38	1.46	1.19	0.80	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	8.78	3.51	1.89	0.68	0.54	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.80	5.26	2.99	1.85	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	11.86	4.28	3.62	3.29	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.10	5.53	1.94	1.52	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	20.25	2.79	2.79	4.54	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.41	4.70	3.06	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.25	3.95	7.19	5.75	1.44	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	6.00	2.59	3.00	1.34	0.10	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.21	2.51	2.96	0.91	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	14.68	5.03	2.94	1.26	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	15.54	4.93	4.63	1.79	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	8.75	3.94	1.14	0.96	0.00	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.45	6.63	4.42	2.58	1.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	28.62	5.15	8.30	4.01	1.72	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	1.68	0.84	3.37	1.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	1.83	0.91	0.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	2.81	0.77	1.53	0.00	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	3.66	1.05	1.05	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	1.54	0.31	0.92	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	1.41	0.94	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	3.05	1.02	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	2.75	0.00	1.18	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	1.85	1.39	0.46	0.93	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	2.88	0.58	1.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	2.45	0.89	1.12	0.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	2.16	0.72	2.16	0.72	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	3.67	2.20	2.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	4.36	0.67	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	1.23	1.23	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	1.72	0.43	0.43	0.43	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	2.27	0.97	0.65	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	1.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	3.20	0.53	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	0.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	3.11	0.00	0.39	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	0.00	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	2.37	0.59	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	1.22	0.00	2.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	1.27	0.00	1.27	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	0.34	0.34	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	0.00	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	0.00	1.22	1.22	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	0.79	0.00	0.00	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	0.00	0.00	0.31	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	1.18	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.13	0.69	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.41	2.47	1.48	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	1.12	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.27	0.64	4.45	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	17.33	2.82	2.82	1.21	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	2.18	6.54	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	1.27	3.80	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.78	4.86	2.43	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	18.94	0.00	4.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.94	1.98	3.57	0.20	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.87	1.95	2.92	1.30	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	1.02	2.04	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	41.01	8.51	25.53	6.96	1.55	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	47.01	23.39	4.49	2.13	0.00	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	49.81	9.73	6.26	6.95	4.63	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	4.27	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	13.46	3.60	3.29	1.34	0.10	0.31
mesothelioma cell line:Mero-25	10850-111F4	4.54	4.09	3.40	0.68	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	15.65	5.62	2.69	1.22	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	3.76	1.33	2.21	0.44	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	12.61	4.20	3.15	0.79	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	9.53	4.94	2.55	1.53	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	28.06	4.30	3.54	1.77	1.52	0.00
mesothelioma cell line:Mero-95	10856-111G1	8.70	3.52	3.52	1.86	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	11.43	4.64	2.48	1.66	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	14.12	5.07	2.35	2.53	0.18	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	31.60	7.00	4.27	3.59	0.85	0.51
mesothelioma cell line:NCI-H28	10845-111E8	7.89	2.29	1.53	0.76	0.25	0.25
mesothelioma cell line:No36	10857-111G2	15.98	3.26	5.22	2.94	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	9.75	2.44	2.44	0.54	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	61.99	10.94	4.03	2.11	0.96	0.00
migratory langerhans cells, donor2	11902-125F3	75.96	17.58	6.23	3.66	1.47	0.24
migratory langerhans cells, donor3	11903-125F4	74.84	33.38	9.69	2.69	0.90	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	14.37	3.26	2.61	1.63	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	6.15	6.57	2.12	0.42	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	27.64	10.83	2.99	4.15	0.23	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	12.56	6.09	2.09	0.57	0.19	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	9.79	4.80	4.07	0.37	0.18	0.92
myeloma cell line:PCM6	10474-106I6	3.95	2.57	0.00	0.00	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	5.07	5.07	2.54	2.03	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	6.86	3.14	1.96	0.59	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.23	4.68	0.45	0.56	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3.16	3.09	0.44	0.15	0.07	0.15
nasal epithelial cells, donor2	12227-129F4	6.07	3.86	0.55	1.66	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	9.89	9.89	5.06	0.92	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	17.77	11.60	11.97	2.06	0.00	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	24.25	12.44	9.70	4.64	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	17.70	8.94	8.57	1.12	0.37	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	4.27	3.32	9.49	0.47	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	31.83	12.35	9.03	5.54	0.32	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	7.65	4.03	1.01	0.81	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	5.72	10.17	1.27	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	13.04	3.73	3.73	0.80	0.00	0.00
neutrophil PMN, donor1	12133-128D9	89.25	178.50	238.00	0.00	0.00	29.75
neutrophil PMN, donor2	12137-128E4	39.84	26.56	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	28.41	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	42.96	22.66	0.85	4.74	1.35	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	14.41	3.20	1.60	3.20	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	14.11	3.53	4.17	2.24	0.96	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	23.65	4.47	3.15	3.68	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	10.03	2.91	4.69	0.19	0.09	0.66
occipital cortex - adult, donor10196	10172-103C1	12.36	4.12	2.06	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	11.54	3.22	4.83	1.07	0.27	0.54
occipital cortex, newborn, donor10223	10355-105E4	5.10	2.91	8.73	0.73	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	6.82	2.89	4.46	1.84	0.00	0.52
occipital lobe, fetal, donor1	10073-102A1	3.43	2.57	3.00	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	6.15	3.71	5.91	0.79	0.32	0.63
olfactory region, adult	10195-103E6	4.97	2.87	3.44	0.76	0.57	0.19
optic nerve, donor1	10277-104E7	22.01	8.00	18.01	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	5.81	2.39	1.25	0.91	0.11	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	6.32	5.91	1.79	0.55	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	3.73	1.69	1.02	0.34	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	6.70	7.62	1.96	0.12	0.35	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	6.76	3.53	2.65	0.29	0.00	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	28.96	29.90	14.02	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	11.24	3.82	2.12	2.97	0.21	0.21
ovary, adult, pool1	10020-101D2	28.74	6.73	13.45	2.27	0.61	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.60	4.40	2.57	0.18	0.00	0.00
pancreas, adult, donor1	10049-101G4	25.40	5.64	0.00	4.70	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	47.24	22.36	16.77	5.87	1.96	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	12.61	2.90	2.73	1.19	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	18.55	7.12	2.15	1.66	0.17	0.17
paracentral gyrus, adult, pool1	10035-101E8	6.86	3.29	6.96	0.92	0.46	0.64
parietal cortex, adult, donor10258	10373-105G4	2.20	0.73	2.94	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	6.58	0.94	2.82	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	4.85	2.28	3.42	0.86	0.00	1.43
parietal lobe, adult, pool1	10034-101E7	7.75	3.44	4.67	1.15	0.09	0.44
parietal lobe, fetal, donor1	10072-101I9	6.79	1.94	5.82	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	10.09	1.12	8.22	1.87	0.37	0.37
parotid gland, adult	10199-103F1	35.15	9.25	6.78	6.78	0.00	0.00
penis, adult	10200-103F2	53.71	10.21	12.35	10.21	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	7.81	3.35	4.09	0.56	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	4.66	3.21	0.58	0.44	0.44	0.15
pineal gland - adult, donor10196	10179-103C8	3.23	1.94	2.58	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	11.84	1.78	2.96	3.55	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	3.76	3.14	5.02	2.51	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	3.04	3.04	6.07	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	16.16	6.78	6.78	2.08	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	8.51	3.40	3.40	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	29.89	11.40	9.14	3.33	0.97	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	22.51	12.32	5.56	1.19	0.66	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	17.43	6.23	3.58	1.40	0.31	0.31
pons, adult, pool1	10033-101E6	8.09	2.41	3.18	0.69	0.17	0.34
postcentral gyrus, adult, pool1	10032-101E5	6.02	3.05	5.93	0.87	0.00	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	43.92	48.10	39.74	0.00	2.09	12.55
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	18.94	11.80	2.33	1.46	0.73	0.29
prostate cancer cell line:PC-3	10439-106E7	21.60	9.26	2.00	1.82	0.00	0.36
prostate, adult, pool1	10022-101D4	66.39	13.88	9.98	12.70	3.63	1.09
putamen, adult, donor10196	10176-103C5	2.12	1.42	1.18	0.24	0.00	0.71
putamen, adult, donor10252	10152-102I8	17.65	1.96	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	7.65	3.28	9.84	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	4.11	1.93	2.17	0.48	0.24	0.72
putamen, newborn, donor10223	10365-105F5	6.75	0.00	3.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	33.17	10.18	4.65	2.33	0.00	0.00
rectum, fetal, donor1	10067-101I4	130.75	18.08	16.69	23.65	12.52	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	13.57	4.45	2.54	1.27	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	8.28	6.21	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	43.14	9.34	13.22	4.27	1.49	0.80
retinoblastoma cell line:Y79	10475-106I7	4.68	3.64	1.30	0.26	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	5.66	4.92	0.74	0.25	0.25	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	35.15	3.94	1.97	12.94	1.69	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.13	3.79	5.30	3.03	0.76	0.00
salivary acinar cells, donor1	11771-123I7	4.21	2.59	1.78	0.65	0.32	0.16
salivary acinar cells, donor2	11772-123I8	3.86	1.51	0.96	0.14	0.14	0.00
salivary acinar cells, donor3	11773-123I9	6.62	0.66	1.32	0.66	0.00	1.99
salivary gland, adult, pool1	10093-102C3	45.76	16.59	8.58	6.29	1.14	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	13.41	6.74	7.00	0.93	0.42	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	18.34	6.11	6.82	1.53	0.71	1.18
seminal vesicle, adult	10201-103F3	46.03	6.88	2.65	12.17	1.06	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	9.23	4.37	1.46	0.97	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.86	3.52	7.30	0.75	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	16.06	3.01	5.02	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	3.09	1.21	0.54	0.40	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	26.20	5.86	1.44	3.32	0.33	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	67.48	6.97	2.58	6.71	1.94	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	7.80	2.13	0.71	2.13	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	12.47	4.08	6.12	1.92	0.24	0.48
skeletal muscle, fetal, donor1	10066-101I3	23.12	4.02	4.02	12.06	6.03	1.01
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	32.19	3.79	5.05	6.31	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	32.02	8.67	2.67	7.00	2.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	21.12	5.67	1.58	2.52	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	5.40	8.48	2.31	0.58	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	81.75	14.50	6.10	6.76	4.29	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2.90	2.09	0.48	0.16	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	24.62	9.59	4.14	3.05	0.65	0.44
small intestine, adult, pool1	10024-101D6	53.87	12.30	5.61	5.85	2.51	1.19
small intestine, fetal, donor1	10064-101I1	17.20	5.90	4.67	3.69	0.98	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	3.59	3.59	0.00	0.51	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	163.86	25.07	12.66	51.95	17.32	1.29
somatostatinoma cell line:QGP-1	10781-110G7	90.06	39.67	9.92	21.17	1.34	1.34
spinal cord - adult, donor10196	10181-103D1	15.37	2.75	6.19	4.13	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	29.96	13.41	12.62	2.76	1.18	1.58
spinal cord, adult, donor10258	10369-105F9	15.22	5.53	8.30	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	15.86	3.05	2.44	1.83	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	5.51	2.76	5.51	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	7.92	4.48	2.54	1.19	0.45	0.30
spleen, adult, pool1	10025-101D7	53.86	21.70	15.75	3.19	0.99	2.42
spleen, fetal, pool1	10044-101F8	34.72	14.78	15.41	2.46	0.64	1.83
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	59.11	15.11	5.59	3.73	1.55	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	4.37	2.85	0.38	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	20.97	5.59	4.19	5.94	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	21.89	3.13	1.95	1.95	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	17.45	5.97	3.71	1.80	0.11	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	3.39	2.97	1.69	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.85	6.77	1.27	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	82.23	16.02	19.22	33.11	14.95	0.00
submaxillary gland, adult	10202-103F4	64.94	9.68	6.84	10.82	1.71	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	20.77	5.61	9.76	1.04	0.21	0.42
substantia nigra, adult, donor10258	10371-105G2	8.79	1.55	4.66	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	9.89	1.41	9.89	2.83	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	6.88	9.17	1.83	0.46	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	4.66	3.56	4.83	0.93	0.34	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	4.99	2.85	4.27	0.71	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	1.76	0.88	2.64	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	11.17	3.14	2.79	1.05	0.00	0.35
tenocyte, donor2	11765-123I1	3.43	1.91	2.29	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	9.27	1.85	4.08	1.11	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	20.06	10.20	5.61	2.38	1.53	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	38.23	10.02	6.01	4.93	0.77	0.31
teratocarcinoma cell line:PA-1	10807-111A6	24.18	11.31	4.96	2.48	0.46	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	36.43	7.24	7.74	9.77	1.14	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	23.45	6.05	9.08	2.65	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	37.84	8.07	8.62	6.98	1.20	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	8.47	3.91	14.01	2.61	0.33	0.00
testis, adult, pool1	10026-101D8	20.72	10.20	10.84	2.58	0.32	1.40
testis, adult, pool2	10096-102C6	8.12	11.73	11.28	0.45	0.00	0.45
thalamus - adult, donor10196	10168-103B6	33.12	8.83	9.94	9.94	0.00	0.00
thalamus, adult, donor10252	10154-103A1	14.53	5.94	6.88	2.34	0.31	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	21.55	26.17	7.70	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	23.22	6.75	8.89	5.76	1.81	0.82
thalamus, newborn, donor10223	10366-105F6	14.96	4.03	15.53	3.45	0.58	1.73
throat, adult	10209-103G2	14.98	3.50	3.00	2.00	0.75	0.00
throat, fetal, donor1	10061-101H7	12.49	5.18	7.62	4.88	2.13	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	2.58	2.38	0.79	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	8.45	9.15	13.92	0.30	0.10	1.49
thymus, fetal, pool1	10043-101F7	11.74	8.52	8.62	0.52	0.10	1.56
thyroid carcinoma cell line:KHM-5M	10776-110G2	15.16	5.45	1.20	1.46	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	12.43	7.82	3.07	1.82	0.84	0.28
thyroid, adult, pool1	10028-101E1	9.24	4.39	4.48	1.49	0.28	0.84
thyroid, fetal, donor1	10060-101H6	9.49	2.37	5.54	0.79	0.26	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	3.08	0.00	0.00	6.16	0.00
tongue, adult	10203-103F5	12.09	3.72	2.33	3.72	0.70	0.23
tongue, fetal, donor1	10059-101H5	20.10	5.52	3.15	6.70	1.18	0.39
tonsil, adult, pool1	10047-101G2	34.46	18.93	13.22	2.10	0.70	1.60
trachea, adult, pool1	10029-101E2	25.85	8.43	8.10	2.21	0.49	1.15
trachea, fetal, donor1	10058-101H4	20.77	5.77	3.85	5.39	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	18.07	4.61	4.61	4.96	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	6.38	4.76	2.13	0.81	0.20	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	6.11	8.77	3.13	0.78	0.16	0.16
tridermal teratoma cell line:HGRT	10694-109G1	17.12	3.81	7.61	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	28.95	4.91	1.86	4.66	0.85	0.00
umbilical cord, fetal, donor1	10057-101H3	64.68	10.43	10.43	18.78	0.00	0.00
uterus, adult, pool1	10100-102D1	52.21	16.55	15.87	8.70	0.68	0.34
uterus, fetal, donor1	10055-101H1	28.67	13.82	5.12	8.19	1.02	0.51
vagina, adult	10204-103F6	54.93	14.86	12.92	16.15	7.11	1.29
vein, adult	10191-103E2	40.77	12.93	11.40	7.89	2.41	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	22.16	12.55	4.81	1.60	0.27	0.00